Quality of life of patients with proximal humerus metastasis treated with cement spacer
Authors Guo W, Gao X, Wang D, Wang T, Tang L, Wang Y, Liu B
Received 12 June 2019
Accepted for publication 23 August 2019
Published 17 September 2019 Volume 2019:11 Pages 8499—8506
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Eileen O'Reilly
Wen Guo,1,* Xin Gao,2,* Dongsheng Wang,2,* Tao Wang,2 Liang Tang,2 Yao Wang,2 Bin Liu3,*
1Department of Orthopedics, Taizhou Peopleʼs Hospital, Taizhou 225300, Jiangsu, People’s Republic of China; 2Orthopaedic Oncology Center, Department of Orthopaedics, Changzheng Hospital, Second Military Medical University, Shanghai 200000, People’s Republic of China; 3Department of Bone and Soft Tissue Neurosurgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wen Guo
Department of Orthopedics, Taizhou People’s Hospital, No.366 Taihu Road, Taizhou 225300, Jiangsu, People’s Republic of China
Department of Bone and Soft Tissue Neurosurgery, Affiliated Tumor Hospital of Guangxi Medical University, 71 He Di Road, Nanning 530021, Guangxi, People’s Republic of China
Purpose: The goal of this study was to determine whether the surgery using cement spacer could improve the quality of life of patients with proximal humerus metastasis.
Patients and methods: This is a retrospective study. The study included 34 patients who had been treated for proximal humerus metastasis between January 2010 and June 2014. The patients were divided into surgical and non-surgical group depending on whether they underwent cement spacer surgery. The patient’s quality of life (QOL) assessment is scheduled at five points—at the initial diagnosis (baseline) and at 1 month, 3 months, 6 months, and 9 months of follow-up. Evaluation tool is Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire.
Results: A total of 34 patients, including 15 patients in the surgery group and 19 patients in the non-surgery group, were enrolled in this retrospective study. In the end, 22 patients finished all evaluations, including 11 patients in the surgical group and 11 patients in the non-surgery group. At the completion of the study, 22 patients had died, including 8 patients in the surgery group and 14 patients in the non-surgery group. After surgical using the cement spacer, the QOL scores of patients at each follow-up point were significantly higher than that of preoperative scores. These scores were also higher than those of the non-surgery group.
Conclusion: The current study indicated that surgical treatment using the cement spacer could upgrade and maintain quality of life for patients with proximal humerus metastasis in the 9-month assessment.
Keywords: cement spacer, proximal humerus metastasis, quality of life, palliative treatment
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]